APhA Pain Institute: Substance Abuse Disorder and Pain Management: How Pharmacists Can Help (pre-registration required)


Managing pain in patients who have mental or behavioral health disorders presents many challenges. Stigma surrounding addiction has detrimental effects on patients with comorbid chronic pain conditions—despite evidence that addiction is a disease with the same genetic transmissibility as many other chronic diseases.

Clinical pharmacists play an integral role in educating these patients about appropriate opioid use. This session features an expert discussing addiction as a chronic disease and how addiction affects treatment.

Pre-registration is required; registration is open at http://elearning.pharmacist.com/products/5335/apha2019-pain-institute-innovative-approaches-to-chronic-pain .

Pharmacist Learning Objectives

At the completion of this application-based activity, participants will be able to:

  1. Define the following terms: physical dependence, tolerance, active addiction, recovery, and substance use disorder.
  2. Demonstrate strategies to treat opioid use disorder while concurrently managing pain.
  3. List tools that assist providers in assessing pain levels in patients who are recovering from addiction and explain how the information from these tools can be utilized when selecting an appropriate analgesic regimen.
  4. Identify methods that support appropriate pain management for patients in recovery from addiction, including opioid treatment agreements, urine testing, and opioid regimen selection.
Ted Parran, MD
Isabel and Carter Wang Professor and Chair in Medical Education
Case Western Reserve University School of Medicine
Learning Level: Level 2
Track: APhA Pain Institute
Session Time Slot(s): 
Thursday, March 21
8:15 AM - 9:15 AM
Washington State Convention Center - Room 608-609
ACPE Pharmacist: 0202-0000-19-001-L01-P
CEUs Pharmacist: 0.1
Activity Type: